Activity and safety of erlotinib as second- and third-line treatment in elderly patients with advanced non-small cell lung cancer: a phase II trial

2010 ◽  
Vol 5 (4) ◽  
pp. 231-235 ◽  
Author(s):  
David Rossi ◽  
Donatella Dennetta ◽  
Marcello Ugolini ◽  
Vincenzo Catalano ◽  
Paolo Alessandroni ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Elderly Patients ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Small Cell ◽  
Line Treatment ◽  
Small Cell Lung ◽  
Third Line ◽  
Third Line Treatment

Pemetrexed and carboplatin, an active option in first-line treatment of elderly patients with advanced non-small cell lung cancer (NSCLC): A phase II trial

Lung Cancer ◽  
2013 ◽  
Vol 80 (2) ◽  
pp. 185-190 ◽  
Author(s):  
Radj Gervais ◽  
Gilles Robinet ◽  
Christelle Clément-Duchêne ◽  
Fabrice Denis ◽  
Claude El Kouri ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Elderly Patients ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Small Cell ◽  
Line Treatment ◽  
Small Cell Lung ◽  
First Line ◽  
First Line Treatment

scholarly journals Phase II Study of Afatinib as Third‐Line Treatment for Patients in Korea With Stage IIIB/IV Non‐Small Cell Lung Cancer Harboring Wild‐Type EGFR

2014 ◽  
Vol 19 (7) ◽  
pp. 702-703 ◽  
Author(s):  
Myung‐Ju Ahn ◽  
Sang‐We Kim ◽  
Byoung‐Chul Cho ◽  
Jin Seok Ahn ◽  
Dae Ho Lee ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Small Cell ◽  
Line Treatment ◽  
Wild Type ◽  
Small Cell Lung ◽  
Third Line ◽  
Third Line Treatment

scholarly journals Tasisulam Sodium (LY573636 Sodium) as Third-Line Treatment in Patients With Unresectable, Metastatic Non–Small-Cell Lung Cancer: A Phase-II Study

2012 ◽  
Vol 7 (6) ◽  
pp. 1053-1057 ◽  
Author(s):  
Giorgio V. Scagliotti ◽  
Robert Ilaria ◽  
Silvia Novello ◽  
J. von Pawel ◽  
Juergen R. Fischer ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Phase Ii Study ◽  
Small Cell ◽  
Line Treatment ◽  
Small Cell Lung ◽  
Third Line ◽  
Third Line Treatment
Sign in / Sign up

Export Citation Format

Share Document